Inquis Medical announced a $75 million Series C financing to scale commercial adoption of its AVENTUS thrombectomy system.
- Amount
- $75M
- Stage
- Series C
- Announced
- 12 January 2026
- Use of funds
- Accelerate nationwide commercial expansion of the AVENTUS system and advance next-generation product pipeline.
- Checked
- Amount and date checked against the press source